GOLM1 and Cirrhosis: In the validation cohort, the median predicted probability using the GLAS algorithm was 0.950 in patients with fibrosis versus 0.944 in patients with cirrhosis, which matches the trend observed for GP73 and LG2m biomarker concentrations in these groups (Figs. 1B and 3B).